Xiaofang Zhou
-
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 and COVID-19 Research 3
- Ophthalmology top 10%
- Retinal Diseases and Treatments 2
- Glaucoma and retinal disorders 2
-
- Viral Infections and Immunology Research 5
-
- Erythrocyte Function and Pathophysiology 3
-
- Blood groups and transfusion 2
-
- Respiratory viral infections research 1
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Transplantation (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaofang Zhou
16 papers receiving 171 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 64
- Ophthalmology 27
- Cardiology and Cardiovascular Medicine 57
- Microbiology 15
- Agronomy and Crop Science 19
Countries citing papers authored by Xiaofang Zhou
This map shows the geographic impact of Xiaofang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Zhou more than expected).
Fields of papers citing papers by Xiaofang Zhou
This network shows the impact of papers produced by Xiaofang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Zhou. The network helps show where Xiaofang Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaofang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 4 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 27 | |
| 7 | 2017 | 13 | |
| 8 | 2017 | 18 | |
| 9 | 2016 | 25 | |
| 10 | 2013 | 17 | |
| 11 | 2012 | 11 | |
| 12 | 2012 | 16 | |
| 13 | 2010 | 1 | |
| 14 | 2009 | 1 | |
| 15 | [Effects of trimetazidine on myocardial metabolism evaluated by PET-CT in patients with ischemic cardiomyopathy]. | 2008 | 2 |
| 16 | Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF). | 2000 | 22 |
About Xiaofang Zhou
Xiaofang Zhou is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Ophthalmology, having authored 16 papers that have together received 173 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (5 papers), Viral gastroenteritis research and epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Retinal Diseases and Treatments (2 papers), Glaucoma and retinal disorders (2 papers), Blood groups and transfusion (2 papers) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (64 citations), Ophthalmology (27 citations) and Cardiology and Cardiovascular Medicine (57 citations). Xiaofang Zhou has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Shangrong Fan, Yiheng Liang, Xiaoping Liu, Ying Zhang, Weiqun Chen, Shuang Li, Longding Liu, Qihan Li, Hongbo Chen and Hongye Li. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.